Design Therapeutics, Inc. (NASDAQ:DSGN - Get Free Report) has been assigned an average rating of "Moderate Buy" from the nine analysts that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, seven have assigned a...
Design Therapeutics, Inc. (NASDAQ:DSGN - Get Free Report) has been assigned an average rating of "Moderate Buy" from the nine analysts that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, seven have assigned a...
US stocks lower as Nasdaq falls 200 points, Dow down 0.04% and S&P 500 down 0.37%. Energy shares up 1.8%, tech stocks down 1.6%. Brady Corp reports strong earnings. Sunshine Biopharma, Virax Biolabs...